Downstream neurodegeneration in Alzheimer's Disease and dementia refers to the progressive spread of neuronal damage from initially affected brain regions to interconnected regions over time. In Alzheimer's, this process starts with the accumulation of beta-amyloid plaques and tau tangles in specific areas responsible for memory and cognition. As these abnormal proteins spread, they disrupt neuronal communication and trigger inflammation, leading to further cell death and cognitive decline.
The spread of neurodegeneration follows neural pathways, affecting regions involved in functions such as language, executive function, and eventually motor control as the disease advances. Understanding this process is crucial for developing treatments that not only target early symptoms but also slow or halt the progression of neurodegeneration across the brain. Research focuses on identifying biomarkers and therapeutic strategies aimed at intervening in these cascading processes to preserve cognitive function and quality of life in affected individuals.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States